President, UNESCO Chair-Life Sciences International
BioMedical Imaging Laboratory, Harvard School of Public Health
Professor, Institute of Subtropical Agriculture, The Chinese Academy of Science
The Journal of Bioequivalence & Bioavailability (JBB) is an academic journal that encompasses a wide range of current research on FDA Bioequivalence, Bioequivalence antipsychotics, Bioequivalence anticancers, Bioequivalence antidiuretics, Bioequivalence antipsychotics, BA/BE Studies, Biosimilars, Advances in Bioavailability and offers a promising platform for the authors to make their valuable contributions towards the journal.
Journal of Bioequivalence & Bioavailability is the best open access journal that aims to publish most complete and reliable source of information on the discoveries and advanced developments in this field in the form of original articles, review articles, case reports, short communications, etc. and provide free online access to it without any restrictions or any other subscriptions to researchers worldwide. Journal of Bioequivalence & Bioavailability is one of the best Open Access journals of Scholarly publishing.
The Bioequivalence Peer Reviewed Journal is proficiently supported by universally prominent Editorial Board members. Bioequivalence journal impact factor is mainly calculated based on the number of articles that undergo single blind peer review process by competent Editorial Board so as to ensure excellence, essence of the work and number of citations received for the same published articles.
Fast Editorial Execution and Review Process (FEE-Review Process):
Journal of Bioequivalence & Bioavailability is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
Articles published in Journal of Bioequivalence & Bioavailability have been cited by esteemed scholars and scientists all around the world. Journal of Bioequivalence & Bioavailability has got h-index 26 , which means every article in Journal of Bioequivalence & Bioavailability has got 26 average citations.
Wiwat Supasena, Ekawan Yoosakul, Mathus Sawpitiporn, Charinthon Seeduang, Suchada Rakphung, Anas Sunhem, Mariam Duereh, Jaturavit Vattanarongkup, Vipada Khaowroongrueng*, Lalinthip Saeaue, Busarat Karachot, Piengthong Narakorn, Porranee Puranajoti and Isariya Techatanawat